Summit Therapeutics plc | TalkMarkets

Latest Posts

Chart Of The Day: Summit Therapeutics Begins To Soar

Article By: Jim Van Meerten

Thursday, January 25, 2024 8:24 PM EDT

Summit Therapeutics Inc., a biopharmaceutical company, researches and develops primarily oncology therapies in the United States and the United Kingdom.

In this article: SMMT

Read

Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact

Article By: ChinaBio® Today

Saturday, December 10, 2022 2:20 PM EDT

In a blockbuster agreement, Guangzhou’s Akeso out-licensed ex-China rights to its bispecific PD-1/VEGF candidate in a deal worth up to $5 billion. Summit Therapeutics will pay $500 million upfront and up to $4.5 billion in milestones.

In this article: SMMT Also: GNNSF, IVBXF

Read

5 Breakout Stocks For Superior Returns

Article By: Swarup Gupta

Friday, February 10, 2017 10:50 AM EDT

Utilizing a breakout investment strategy is a favored choice of active investors who are content only with returns superior to most other investments.

In this article: GNK, CBAY, CMRX, SMMT, MODN

Read